2
Views
1
CrossRef citations to date
0
Altmetric
Symposium HIV and AIDS: ANTIRETROVIRAL THERAPY

Antiretroviral therapy in HIV-infected adults Which regimens are recommended?

Pages 47-55 | Published online: 05 Dec 2017

References

  • Choi S, Lagakos SW, Schooley RT, et al. CD4+ lymphocytes are an incomplete surrogate marker for clinical progression in persons with asymptomatic HIV infection taking zidovudine. Ann Intern Med 1993; 118(9): 674–80
  • NIAID issues preliminary recommendations on antiretrovirals. AIDS Clin Care 1993; 6(8): 64–5
  • Hirsch MS, D'Aquila RT. Therapy for human immunodeficiency virus infection. N Engl J Med 1993; 328(23): 1686–95
  • Aboulker JP, Swart AM. Preliminary analysis of the Concorde trial: Concorde Coordinating Committee. (Letter) Lancet 1993; 341(8849): 889–90
  • Volberding PA, Lagakos SW, Koch MA, et al. Zidovudine in asymptomatic human immunodeficiency virus infection: a controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. N Engl J Med 1990; 322(14): 941–9
  • Cooper DA, Gatell JM, Kroon S, et al. Zidovudine in persons with asymptomatic HIV infection and CD4+ cell counts greater than 400 per cubic millimeter. N Engl J Med 1993; 329(5): 297–303
  • Hamilton JD, Harrigan PM, Simberkoff MS, et al. A controlled trial of early versus late treatment with zidovudine in symptomatic human immunodeficiency virus infection: results of the Veterans Affairs Cooperative Study. N Engl J Med 1992; 326(7): 437–43
  • Velia S, Giuliano M, Pezzetti P, et al. Survival of zidovudine-treated patients with AIDS compared with that of contemporary untreated patients. JAMA 1992; 267(9): 1232–6
  • Edlin BR, St Clair MH, Pitha PM, et al. In-vitro resistance to zidovudine and alphainterferon in HIV-1 isolates from patients: correlations with treatment duration and response. Ann Intern Med 1992; 117(6): 457–60 [erratum, Ann Intern Med 1992; 117(10): 879]
  • Erice A, Mayers DL, Strike DG, et al. Brief report: primary infection with zidovudine-resistant human immunodeficiency virus type 1. N Engl J Med 1993; 328(16): 1163–5
  • Kahn JO, Lagakos SW, Richman DD, et al. A controlled trial comparing continued zidovudine with didanosine in human immunodeficiency virus infection. N Engl J Med 1992; 327(9): 581–7
  • Meng TC, Fischl MA, Boota AM, et al. Combination therapy with zidovudine and dideoxycytidine in patients with advanced human immunodeficiency virus infection: a phase I/II study. Ann Intern Med 1992; 116(1): 13–20
  • Skowron G, Bozzette SA, Lim L, et al. Alternating and intermittent regimens of zidovudine and dideoxycytidine in patients with AIDS or AIDS-related complex. Ann Intern Med 1993; 118(5): 321–30
  • Collier A, Henry K, Japour A, et al. Switching and combining antiretroviral therapies. AIDS Clin Care 1993; 5(5): 33–7

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.